Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

September 17, 2025

HMP · Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional

Greg Mattingly, MD examines safer alternatives and their limitations.

Related Content

What’s the Role of Amantadine in Anticholinergic Deprescription?
Treatment Options and Managing Side Effects in Schizophrenia
Assessing Anticholinergic Burden
Are There Guidelines for Deprescribing Anticholinergics?
How to Taper Anticholinergic Medications Safely
Patient Case Studies: Successful Deprescription of Anticholinergics
Can Anticholinergic Medications Make Movement Disorders Worse?
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy